{"id":594133,"date":"2022-04-01T11:32:02","date_gmt":"2022-04-01T11:32:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=594133"},"modified":"2022-04-01T11:32:02","modified_gmt":"2022-04-01T11:32:02","slug":"acoustic-neuroma-market-size-epidemiology-pipeline-therapies-competitive-analysis-and-companies-by-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/acoustic-neuroma-market-size-epidemiology-pipeline-therapies-competitive-analysis-and-companies-by-delveinsight_594133.html","title":{"rendered":"Acoustic Neuroma Market Size, Epidemiology, Pipeline, Therapies, Competitive Analysis and Companies by DelveInsight"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1648783963.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Acoustic Neuroma Market Size, Epidemiology, Pipeline, Therapies, Competitive Analysis and Companies by DelveInsight\" src=\"https:\/\/www.abnewswire.com\/uploads\/1648783963.jpeg\" alt=\"Acoustic Neuroma Market Size, Epidemiology, Pipeline, Therapies, Competitive Analysis and Companies by DelveInsight\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Acoustic Neuroma Market<\/div>\n<\/div>\n<\/div>\n<p style=\"text-align: justify;\"><strong>Acoustic neuromas<\/strong>&nbsp;also known as vestibular schwannomas, usually grows slowly over a period of years. Usually they do not invade the brain, but can push on it as they grow. As the tumor grows, they press the nearby cranial nerves that control the muscles enabling facial expression and sensation. If the tumor becomes large enough to press on the brain stem or cerebellum, it can be deadly. They account for almost 8% of all tumors inside the skull. The prevalence rate is 1 out of every 100,000 individuals per year.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">DelveInsight&#8217;s <strong>Acoustic Neuroma Market Insights, Epidemiology, and Market Forecast-2030<\/strong>&nbsp;report delivers an in-depth understanding of the Acoustic Neuroma, historical and forecasted epidemiology as well as the Acoustic Neuroma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Some facts of <\/strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/acoustic-neuroma-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>Acoustic Neuroma Market<\/strong><\/a><strong> are:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Globally around 1-20 people in every million are diagnosed each year with an acoustic neuroma.<\/li>\n<li>Acoustic neuromas account for about 6 cases in every 100 patients with brain tumours. They are more common in middle-aged adults and are rare in children.<\/li>\n<li>Acoustic Neuroma seem to be more common in women than in men.<\/li>\n<li>Acoustic neuromas tend to affect adults aged 30 to 60 and usually have no obvious cause, although a small number of cases are the result of a genetic condition called neurofibromatosis type 2 (NF2).<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Download Sample Report here: <\/strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/acoustic-neuroma-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>https:\/\/www.delveinsight.com\/sample-request\/acoustic-neuroma-market<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Scope of <\/strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/acoustic-neuroma-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>Acoustic Neuroma Market<\/strong><\/a><strong> are:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>The report covers the descriptive overview of Acoustic Neuroma, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies<\/li>\n<li>Comprehensive insight has been provided into the Acoustic Neuroma epidemiology and treatment in the 7MM<\/li>\n<li>Additionally, an all-inclusive account of both the current and emerging therapies for Acoustic Neuroma are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape<\/li>\n<li>A detailed review of Acoustic Neuroma market; historical and forecasted is included in the report, covering drug outreach in the 7MM<\/li>\n<li>The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Acoustic Neuroma market<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Request for Sample Report here: <\/strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/acoustic-neuroma-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=apr\"><strong>https:\/\/www.delveinsight.com\/sample-request\/acoustic-neuroma-market<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Some of Acoustic Neuroma Companies are:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Pfizer Inc.<\/li>\n<li>Merck &amp; Co., Inc<\/li>\n<li>Novartis AG<\/li>\n<li>F. Hoffmann-La Roche Ag<\/li>\n<li>Toshiba Medical Systems Corporation<\/li>\n<li>GE Healthcare<\/li>\n<li>Philips Healthcare<\/li>\n<li>Shimadzu Corporation<\/li>\n<li>Siemens Healthcare<\/li>\n<li>And Many Others<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Acoustic Neuroma Therapies are:<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Selumetinib<\/li>\n<li>Brigatinib<\/li>\n<li>Everolimus<\/li>\n<li>And Many Others<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Table of Contents:<\/strong><\/p>\n<p style=\"text-align: justify;\">1. Key Insights<\/p>\n<p style=\"text-align: justify;\">2. Executive Summary of Acoustic Neuroma<\/p>\n<p style=\"text-align: justify;\">3. Competitive Intelligence Analysis for Acoustic Neuroma<\/p>\n<p style=\"text-align: justify;\">4. Acoustic Neuroma: Market Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">4.1. Acoustic Neuroma Total Market Share (%) Distribution in 2018<\/p>\n<p style=\"text-align: justify;\">4.2. Acoustic Neuroma Total Market Share (%) Distribution in 2030<\/p>\n<p style=\"text-align: justify;\">5. Acoustic Neuroma: Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\">6. Patient Journey<\/p>\n<p style=\"text-align: justify;\">7. Acoustic Neuroma Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\">8. Treatment Algorithm, Current Treatment, and Medical Practices<\/p>\n<p style=\"text-align: justify;\">9. Unmet Needs<\/p>\n<p style=\"text-align: justify;\">10. Key Endpoints of Acoustic Neuroma Treatment<\/p>\n<p style=\"text-align: justify;\">11. Marketed Products<\/p>\n<p style=\"text-align: justify;\">List to be continued in report<\/p>\n<p style=\"text-align: justify;\">12. Emerging Therapies<\/p>\n<p style=\"text-align: justify;\">List to be continued in report<\/p>\n<p style=\"text-align: justify;\">13. Acoustic Neuroma: Seven Major Market Analysis<\/p>\n<p style=\"text-align: justify;\">14. Attribute analysis<\/p>\n<p style=\"text-align: justify;\">15. 7MM: Market Outlook<\/p>\n<p style=\"text-align: justify;\">16. Access and Reimbursement Overview of Acoustic Neuroma<\/p>\n<p style=\"text-align: justify;\">17. KOL Views<\/p>\n<p style=\"text-align: justify;\">18. Market Drivers<\/p>\n<p style=\"text-align: justify;\">19. Market Barriers<\/p>\n<p style=\"text-align: justify;\">20. Appendix<\/p>\n<p style=\"text-align: justify;\">21. DelveInsight Capabilities<\/p>\n<p style=\"text-align: justify;\">22. Disclaimer<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Related Reports:<\/strong><\/p>\n<p style=\"text-align: justify;\"><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/urolithiasis-market\" target=\"_blank\"><strong>Urolithiasis Market<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\">DelveInsight&#8217;s &#8220;Urolithiasis Market Insights, Epidemiology, and Market Forecast-2032&#8221; report delivers an in-depth understanding of the Urolithiasis, historical and forecasted epidemiology as well as the Urolithiasis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>About Delveinsight:&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\">DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56434.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Ankit Nigam<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=acoustic-neuroma-market-size-epidemiology-pipeline-therapies-competitive-analysis-and-companies-by-delveinsight\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +19193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Albany<br \/><strong>State:<\/strong> New York<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/report-store\/acoustic-neuroma-market\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/report-store\/acoustic-neuroma-market<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/report-store\/acoustic-neuroma-market\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=acoustic-neuroma-market-size-epidemiology-pipeline-therapies-competitive-analysis-and-companies-by-delveinsight\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Acoustic Neuroma Market Acoustic neuromas&nbsp;also known as vestibular schwannomas, usually grows slowly over a period of years. Usually they do not invade the brain, but can push on it as they grow. As the tumor grows, they press the nearby &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/acoustic-neuroma-market-size-epidemiology-pipeline-therapies-competitive-analysis-and-companies-by-delveinsight_594133.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,435,405,406,404],"tags":[],"class_list":["post-594133","post","type-post","status-publish","format-standard","hentry","category-Business","category-Europe","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/594133","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=594133"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/594133\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=594133"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=594133"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=594133"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}